At the molecular level, Coffin–Lowry syndrome is caused by loss-of-function mutations in RSK2 (also known as RPS6KA3), which encodes a serine/threonine protein kinase in humans. The gene discussed is RPS6KA3; the disease is Coffin-Lowry syndrome.